Zynerba Pharmaceuticals Announces Publication of Zygel™ (ZYN002) 12-week Open Label Fragile X Syndrome Data in the Journal of Neurodevelopmental Disorders August 6, 2019 - NASDAQ Companies 0 » View More News for August 06, 2019
